Baccus, L., Dheur, A., Salmon, A., Delbecque, K., Goffin, F., De Cuypere, M., PLEYERS, C., Lovinfosse, P., Danthine, D., THILLE, A., Gonne, E., Gennigens, C., Kridelka, F., & Kakkos, A. (2024). 414 Potential association between quantified LVSI status and molecular profile in predicting nodal metastases for patient suffering early-stage endometrial cancer. International Journal of Gynecological Cancer, 34, 177-A178. Peer Reviewed verified by ORBi |
Streel, S.* , Salmon, A.* , DHEUR, A., Bours, V., LEROI, N., Habran, L., Delbecque, K., Goffin, F., PLEYERS, C., Kakkos, A., Gonne, E., Seidel, L., Kridelka, F.* , & Gennigens, C.*. (02 March 2023). Diagnostic Performance of Immunohistochemistry Compared to Molecular Techniques for Microsatellite Instability and p53 Mutation Detection in Endometrial Cancer. International Journal of Molecular Sciences, 24 (5), 4866. doi:10.3390/ijms24054866 Peer Reviewed verified by ORBi * These authors have contributed equally to this work. |
DHEUR, A., Salmon, A., Streel, S., Bours, V., Delbecque, K., Gonne, E., PLEYERS, C., De Cuypere, M., Goffin, F., Lovinfosse, P., Kridelka, F., Kakkos, A., & Gennigens, C. (February 2023). p53 status : a strong negative prognostic factor in endometrial carcinoma [Poster presentation]. 25th BSMO Annual Meeting 2023, Hasselt, Belgium. Peer reviewed |
Salmon, A., Streel, S., DHEUR, A., Bours, V., Delbecque, K., Gonne, E., PLEYERS, C., De Cuypere, M., Goffin, F., Lovinfosse, P., Kakkos, A., Kridelka, F., & Gennigens, C. (February 2023). Agreement between immunohistochemistry and molecular techniques to assess microsatellite instability and p53 status in endometrial cancer [Poster presentation]. 25th BSMO Annual Meeting 2023, Hasselt, Belgium. Peer reviewed |
Dheur, A., Bours, V., De Cuypere, M., Delbecque, K., Gennigens, C., Goffin, F., Gonne, E., HERMESSE, J., Kridelka, F., Lovinfosse, P., PLEYERS, C., Salmon, A., & Kakkos, A. (October 2022). 2022-RA-193-ESGO Cost-effectiveness of molecular profiling for endometrial neoplasia: a single institution experience [Poster presentation]. 23rd European Congress on Gynaecological Oncology. doi:10.1136/ijgc-2022-esgo.203 Peer reviewed |
Salmon, A., Dheur, A., Bours, V., Delbecque, K., Gonne, E., PLEYERS, C., De Cuypere, M., Goffin, F., Lovinfosse, P., Kridelka, F., Kakkos, A., & Gennigens, C. (October 2022). Endometrial cancer: lymphovascular space invasion is a negative prognostic factor [Poster presentation]. 23rd European Congress on Gynaecological Oncology. doi:10.1136/ijgc-2022-esgo.264 Peer reviewed |
DHEUR, A., Bours, V., De Cuypere, M., Delbecque, K., Gennigens, C., Goffin, F., Gonne, E., HERMESSE, J., Kakkos, A., Lovinfosse, P., PLEYERS, C., Salmon, A., & Kridelka, F. (29 September 2022). Defining prognostic risk groups amongst patients with endometrial cancer:respective role of 2009 figo stage and molecular profile [Poster presentation]. IGCS 2022, New York, United States. Peer reviewed |
Salmon, A., DHEUR, A., Bours, V., Delbecque, K., Gonne, E., PLEYERS, C., De Cuypere, M., Goffin, F., Lovinfosse, P., Kakkos, A., Kridelka, F., & Gennigens, C. (29 September 2022). Endometrial cancer: agreement between P53 immunohistochemistry and TP53 mutational analysis ? [Poster presentation]. IGCS 2022, New York, United States. Peer reviewed |
Gennigens, C., DHEUR, A., Bours, V., Delbecque, K., Gonne, E., PLEYERS, C., Seidel, L., Streel, S., De Cuypere, M., Goffin, F., Lovinfosse, P., Kakkos, A., Kridelka, F., & Salmon, A. (2022). 2022-RA-967-ESGO Endometrial cancer: agreement between microsatellite instability in immunohistochemistry and molecular analysis ? International Journal of Gynecological Cancer. doi:10.1136/ijgc-2022-ESGO.266 Peer Reviewed verified by ORBi |